Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹2,435.50
9.00 (0.37%)
Medium VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹39.10K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
55.1
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹1,603.5+51.9%
52W High₹2,474-1.6%
Current Price
₹2,435.50
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹1,948.40
Upper Circuit₹2,922.60
Reference Price
₹2,435.50
Investment Checklist
Inverse Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹2536.5
Inverse Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹2519.1
Composite score 68.22 (STRONG_BUY) with 91.9% confidence
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
RSI at 78.3 — overbought, pullback risk
Technical Analysis
Technical Analysis
Analysis from 2026-07-11
Confidence
92%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
EMA20
2318.34
EMA50
2224.73
EMA200
1991.56
Price Action
UPTREND
BULLISH
Higher Highs7
Higher Lows7
Lower Highs2
Lower Lows2
Support & Resistance Levels
Resistance (Above)
No recent resistance detected
Support (Below)
₹2292.65
₹2224.90
₹2195.00
₹2163.10
₹2114.70
Volume Analysis
TrendINCREASING
Change+123.40%
Unusual VolumeNo
Stop Loss Levels
Fixed Risk
1% Risk₹2411.14
3% Risk₹2362.43
5% Risk₹2313.72
7% Risk (Custom)
₹2265.01Technical Levels
1x ATR (Volatility)₹2383.55
2x ATR (Swing)₹2331.60
3x ATR (Trend)₹2279.65
Immediate Support₹2292.65
Moving Averages
EMA 9 (Short-term)₹2384.03
EMA 20 (Medium-term)₹2318.34
EMA 50 (Trend)₹2224.73
EMA 200 (Long-term)₹1991.56
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹893.5 Cr | ₹1,093.9 Cr | ₹1,084.9 Cr | ₹1,064.7 Cr |
| Net Profit | ₹145.7 Cr | ₹202.4 Cr | ₹207.8 Cr | ₹197.9 Cr |
| EPS | — | ₹12.99 | ₹13.29 | ₹12.63 |
| Operating Profit | ₹239.9 Cr | ₹315.4 Cr | ₹324.9 Cr | ₹314.1 Cr |
ROE
19.21%
ROCE
25.95%
Debt/Equity
0.01
Current Ratio
3.04
OPM
29.50%
NPM
18.59%
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.7 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.6 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 22.8 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.3 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.1 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.1 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 25.7 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 93.4 | ₹83.02K Cr mid Cap | |
| JB Chemicals & Pharmaceuticals Limited | ₹2,435.50 | -0.37% | 55.1 | ₹39.10K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 29 May 2026 | Dividend - Rs 9.30 Per Share | DIVIDEND |
| 11 Feb 2026 | Interim Dividend - Rs 12.70 Per Share | INTERIM_DIVIDEND |
| 30 Jul 2025 | Dividend - Rs 7 Per Share | DIVIDEND |
| 07 Feb 2025 | Interim Dividend - Rs 8.50 Per Share | INTERIM_DIVIDEND |
| 14 Aug 2024 | Dividend - Rs 6.75 Per Share | DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for JBCHEPHARM
View AllNEWS
positive
Business Standard - Markets 4d ago
J B Chemicals & Pharmaceuticals Ltd up for fifth session
J B Chemicals & Pharmaceuticals Ltd is quoting at Rs 2419.6, up 1.24% on the day as on 12:44 IST on the NSE. The stock is up 48.86% in last one year as compared to a 4.11% spurt in NIFTY and a 16.43% spurt in the Nifty Pharma.
AONELIQUIDAONENIFTYAONETMMQ50AONETOTALBIOFILCHEMCHEMICALGROWWCHEMIOLCPJBCHEPHARMJGCHEMPHARMABEESChemicalsFinancial Services
NEWS
neutral
Business Standard - Markets 4d ago
Saraswati Commercial (India) Ltd leads gainers in 'B' group
DB (International) Stock Brokers Ltd, IOL Chemicals & Pharmaceuticals Ltd, Kaushalya Infrastructure Development Corpn Ltd and Kothari Industrial Corporation Ltd are among the other gainers in the BSE's 'B' group today, 07 July 2026.
ARSSBLBIOFILCHEMBSEDBSTOCKBROIOLCPJBCHEPHARMJGCHEMKAUSHALYAKOTARISUGKOTICZSARACOMChemicalsConsumer Services
positive
CNBC TV18 - Markets 5d ago
NCLT clears Torrent Pharma's merger with JB Chemicals
The National Company Law Tribunal (NCLT) has approved the merger of JB Chemicals & Pharmaceuticals with Torrent Pharmaceuticals. The amalgamation will take effect after the company files the tribunal's order with the Registrar of Companies.
BIOFILCHEMIOLCPJBCHEPHARMJGCHEMTAKETORNTPHARMChemicalsHealthcare